전체 프로그램

CGTLimited DatastaleGyala TherapeuticsPhase 1

CD84-CART (CD84-CART)

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 2Status Recruiting

CGTLimited DatastaleBiohaven Pharmaceuticals, Inc.Phase 2

CIML NK Cell Infusion (CIML NK Cell Infusion)

Squamous Cell Carcinoma of the Head and Neck; Recurrent Head and Neck Squamous Cell Carcinoma · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+4

Trials 2Status Active

CGTLimited DatastaleMasonic Cancer Center, Universi…Phase 2

Donor TCR α/β-depleted Graft/ATG (Donor TCR α/β-depleted Graft/ATG)

Acute Myeloid Leukemia; Myelodysplastic Syndrome · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+3

Trials 2Status Active

AntibodyLimited DatastaleJanssenPhase 1

daratumumab (Darzalex, Indium In 111-DOTA-Daratumumab)

Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia · FRα

#FR#Antibody#Phase1#monoclonal-antibody#AcuteLymphoblasticLeukemia+2

Trials 2Status Recruiting

CGTLimited DatastaleAvenCell Europe GmbHPhase 1

IMP (UniCAR02-T, UniCAR02-T (IMP))

Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#cell-gene-therapy#CAR-T+2

Trials 2Status Discontinued

CGTLimited DatastaleShanghai AbelZeta Ltd.Phase 1

A-CAR028 (A-CAR028)

Acute Myeloid Leukemia (AML); CAR-T Cell Therapy · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#cell-gene-therapy#CAR-T+3

Trials 1Status Recruiting

CGTLimited DatastaleAvenCell Europe GmbHPhase 1

Allo-RevCAR01-T (Allo-RevCAR01-T)

Acute Myeloid Leukemia, in Relapse; Acute Myeloid Leukemia Refractory · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5

Trials 1Status Recruiting

CGTLimited DatastaleMustang Bio, Inc.Phase 1

Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes (Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes)

Adult Acute Myeloid Leukemia in Remission; Acute Biphenotypic Leukemia · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+5

Trials 1Status Recruiting

CGTLimited DatastaleIRCCS Azienda Ospedaliero-Unive…Preclinical

Alloreactive NK cell infusion (Alloreactive NK cell infusion)

Adult Acute Myeloid Leukemia in Remission · Adult Acute Myeloid Leukemia in Remissio

#AdultAcuteMyeloidLeukemiainRemis#CGT#Preclinical#cell-gene-therapy#CAR-T+2

Trials 1Status Active

CGTLimited DatastaleSecond Affiliated Hospital, Sch…Phase 1

Anti-LILRA6 CAR-T cells (Anti-LILRA6 CAR-T cells)

Refractory Acute Myeloid Leukemia; Recurrent Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 1Status Recruiting

CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

Relapsed or Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3

Trials 1Status Discontinued

CGTLimited DatastaleRoswell Park Cancer InstitutePhase 1

Autologous Anti-CD83 CAR T-cells (Autologous Anti-CD83 CAR T-cells)

Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 1Status Recruiting

CGTLimited DatastaleMustang Bio, Inc.Phase 1

Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes (Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes)

Adult Acute Myeloid Leukemia in Remission; Acute Biphenotypic Leukemia · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 1Status Recruiting

CGTLimited DatastaleFred Hutchinson Cancer CenterPhase 1

Autologous HLA-A02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells (Autologous HLA-A02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2

Trials 1Status Recruiting

CGTLimited DatastaleSheba Medical CenterPhase 3

CAR-T CD19 (CAR-T CD19)

Acute Myeloid Leukemia · CD19

#CD19#CGT#Phase3#cell-gene-therapy#CAR-T+3

Trials 1Status Active

CGTLimited DatastaleZhujiang HospitalPreclinical

AML (CART therapy in Acute myeloid leukemia, CART therapy in Acute myeloid leukemia(AML))

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+4

Trials 1Status Discontinued

CGTLimited DatastaleThe First Affiliated Hospital o…Phase 2

CART-38 (CART-38)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+2

Trials 1Status Active

CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

CD117 CAR T-cells (CD117 CAR T-cells)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2

Trials 1Status Recruiting

CGTLimited DatastaleBeijing JD Biotech Co. LTD.Phase 1

CD123-CAR-NK cells (CD123-CAR-NK cells)

Acute Myeloid Leukemia Refractory; Acute Myeloid Leukemia Recurrent · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 1Status Active

CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

CD123-CD33 cCAR T cells (CD123-CD33 cCAR T cells)

Hematologic Malignancy; Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 1Status Active

2 / 4 pages

← Previous Next →

다음 갱신 D-6 · 마지막 9월 2일 · 방문 606 / 70,440

Biologic만FDA만

CGTLimited DatastaleGyala TherapeuticsPhase 1

CD84-CART (CD84-CART)

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 2Status Recruiting

CGTLimited DatastaleBiohaven Pharmaceuticals, Inc.Phase 2

CIML NK Cell Infusion (CIML NK Cell Infusion)

Squamous Cell Carcinoma of the Head and Neck; Recurrent Head and Neck Squamous Cell Carcinoma · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+4

Trials 2Status Active

CGTLimited DatastaleMasonic Cancer Center, Universi…Phase 2

Donor TCR α/β-depleted Graft/ATG (Donor TCR α/β-depleted Graft/ATG)

Acute Myeloid Leukemia; Myelodysplastic Syndrome · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+3

Trials 2Status Active

AntibodyLimited DatastaleJanssenPhase 1

daratumumab (Darzalex, Indium In 111-DOTA-Daratumumab)

Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia · FRα

#FR#Antibody#Phase1#monoclonal-antibody#AcuteLymphoblasticLeukemia+2

Trials 2Status Recruiting

CGTLimited DatastaleAvenCell Europe GmbHPhase 1

IMP (UniCAR02-T, UniCAR02-T (IMP))

Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#cell-gene-therapy#CAR-T+2

Trials 2Status Discontinued

CGTLimited DatastaleShanghai AbelZeta Ltd.Phase 1

A-CAR028 (A-CAR028)

Acute Myeloid Leukemia (AML); CAR-T Cell Therapy · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#cell-gene-therapy#CAR-T+3

Trials 1Status Recruiting

CGTLimited DatastaleAvenCell Europe GmbHPhase 1

Allo-RevCAR01-T (Allo-RevCAR01-T)

Acute Myeloid Leukemia, in Relapse; Acute Myeloid Leukemia Refractory · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5

Trials 1Status Recruiting

CGTLimited DatastaleMustang Bio, Inc.Phase 1

Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes (Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes)

Adult Acute Myeloid Leukemia in Remission; Acute Biphenotypic Leukemia · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+5

Trials 1Status Recruiting

CGTLimited DatastaleIRCCS Azienda Ospedaliero-Unive…Preclinical

Alloreactive NK cell infusion (Alloreactive NK cell infusion)

Adult Acute Myeloid Leukemia in Remission · Adult Acute Myeloid Leukemia in Remissio

#AdultAcuteMyeloidLeukemiainRemis#CGT#Preclinical#cell-gene-therapy#CAR-T+2

Trials 1Status Active

CGTLimited DatastaleSecond Affiliated Hospital, Sch…Phase 1

Anti-LILRA6 CAR-T cells (Anti-LILRA6 CAR-T cells)

Refractory Acute Myeloid Leukemia; Recurrent Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 1Status Recruiting

CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

Relapsed or Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3

Trials 1Status Discontinued

CGTLimited DatastaleRoswell Park Cancer InstitutePhase 1

Autologous Anti-CD83 CAR T-cells (Autologous Anti-CD83 CAR T-cells)

Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 1Status Recruiting

CGTLimited DatastaleMustang Bio, Inc.Phase 1

Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes (Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes)

Adult Acute Myeloid Leukemia in Remission; Acute Biphenotypic Leukemia · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 1Status Recruiting

CGTLimited DatastaleFred Hutchinson Cancer CenterPhase 1

Autologous HLA-A02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells (Autologous HLA-A02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2

Trials 1Status Recruiting

CGTLimited DatastaleSheba Medical CenterPhase 3

CAR-T CD19 (CAR-T CD19)

Acute Myeloid Leukemia · CD19

#CD19#CGT#Phase3#cell-gene-therapy#CAR-T+3

Trials 1Status Active

CGTLimited DatastaleZhujiang HospitalPreclinical

AML (CART therapy in Acute myeloid leukemia, CART therapy in Acute myeloid leukemia(AML))

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+4

Trials 1Status Discontinued

CGTLimited DatastaleThe First Affiliated Hospital o…Phase 2

CART-38 (CART-38)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+2

Trials 1Status Active

CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

CD117 CAR T-cells (CD117 CAR T-cells)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2

Trials 1Status Recruiting

CGTLimited DatastaleBeijing JD Biotech Co. LTD.Phase 1

CD123-CAR-NK cells (CD123-CAR-NK cells)

Acute Myeloid Leukemia Refractory; Acute Myeloid Leukemia Recurrent · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 1Status Active

CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

CD123-CD33 cCAR T cells (CD123-CD33 cCAR T cells)

Hematologic Malignancy; Acute Myeloid Leukemia · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+4

Trials 1Status Active

2 / 4 pages

← Previous Next →

CD84-CART (CD84-CART)

CIML NK Cell Infusion (CIML NK Cell Infusion)

Donor TCR α/β-depleted Graft/ATG (Donor TCR α/β-depleted Graft/ATG)

daratumumab (Darzalex, Indium In 111-DOTA-Daratumumab)

IMP (UniCAR02-T, UniCAR02-T (IMP))

A-CAR028 (A-CAR028)

Allo-RevCAR01-T (Allo-RevCAR01-T)

Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes (Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes)

Alloreactive NK cell infusion (Alloreactive NK cell infusion)

Anti-LILRA6 CAR-T cells (Anti-LILRA6 CAR-T cells)

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

Autologous Anti-CD83 CAR T-cells (Autologous Anti-CD83 CAR T-cells)

Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes (Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes)

Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells (Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells)

CAR-T CD19 (CAR-T CD19)

AML (CART therapy in Acute myeloid leukemia, CART therapy in Acute myeloid leukemia(AML))

CART-38 (CART-38)

CD117 CAR T-cells (CD117 CAR T-cells)

CD123-CAR-NK cells (CD123-CAR-NK cells)

CD123-CD33 cCAR T cells (CD123-CD33 cCAR T cells)

전체 프로그램

CD84-CART (CD84-CART)

CIML NK Cell Infusion (CIML NK Cell Infusion)

Donor TCR α/β-depleted Graft/ATG (Donor TCR α/β-depleted Graft/ATG)

daratumumab (Darzalex, Indium In 111-DOTA-Daratumumab)

IMP (UniCAR02-T, UniCAR02-T (IMP))

A-CAR028 (A-CAR028)

Allo-RevCAR01-T (Allo-RevCAR01-T)

Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes (Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes)

Alloreactive NK cell infusion (Alloreactive NK cell infusion)

Anti-LILRA6 CAR-T cells (Anti-LILRA6 CAR-T cells)

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

Autologous Anti-CD83 CAR T-cells (Autologous Anti-CD83 CAR T-cells)

Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes (Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes)

Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells (Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells)

CAR-T CD19 (CAR-T CD19)

AML (CART therapy in Acute myeloid leukemia, CART therapy in Acute myeloid leukemia(AML))

CART-38 (CART-38)

CD117 CAR T-cells (CD117 CAR T-cells)

CD123-CAR-NK cells (CD123-CAR-NK cells)

CD123-CD33 cCAR T cells (CD123-CD33 cCAR T cells)

전체 프로그램

CD84-CART (CD84-CART)

CIML NK Cell Infusion (CIML NK Cell Infusion)

Donor TCR α/β-depleted Graft/ATG (Donor TCR α/β-depleted Graft/ATG)

daratumumab (Darzalex, Indium In 111-DOTA-Daratumumab)

IMP (UniCAR02-T, UniCAR02-T (IMP))

A-CAR028 (A-CAR028)

Allo-RevCAR01-T (Allo-RevCAR01-T)

Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes (Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes)

Alloreactive NK cell infusion (Alloreactive NK cell infusion)

Anti-LILRA6 CAR-T cells (Anti-LILRA6 CAR-T cells)

Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes (Autologous Anti-CD 123 CAR TCR/4-1BB-expressing T-lymphocytes)

Autologous Anti-CD83 CAR T-cells (Autologous Anti-CD83 CAR T-cells)

Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes (Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes)

Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells (Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells)

CAR-T CD19 (CAR-T CD19)

AML (CART therapy in Acute myeloid leukemia, CART therapy in Acute myeloid leukemia(AML))

CART-38 (CART-38)

CD117 CAR T-cells (CD117 CAR T-cells)

CD123-CAR-NK cells (CD123-CAR-NK cells)

CD123-CD33 cCAR T cells (CD123-CD33 cCAR T cells)

Autologous HLA-A02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells (Autologous HLA-A02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells)

Autologous HLA-A02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells (Autologous HLA-A02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells)

Autologous HLA-A02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells (Autologous HLA-A02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells)